BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16614319)

  • 21. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease.
    Horne BD; Camp NJ; Anderson JL; Mower CP; Clarke JL; Kolek MJ; Carlquist JF;
    J Am Coll Cardiol; 2007 May; 49(20):2053-60. PubMed ID: 17512363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.
    Baessler A; Fischer M; Mayer B; Koehler M; Wiedmann S; Stark K; Doering A; Erdmann J; Riegger G; Schunkert H; Kwitek AE; Hengstenberg C
    Hum Mol Genet; 2007 Apr; 16(8):887-99. PubMed ID: 17324965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors.
    Gong R; Liu Z; Li L
    Arthritis Rheum; 2007 May; 56(5):1608-17. PubMed ID: 17469143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.
    Chang YC; Chang TJ; Jiang YD; Kuo SS; Lee KC; Chiu KC; Chuang LM
    Diabetes; 2007 Oct; 56(10):2631-7. PubMed ID: 17579206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction.
    Mannila MN; Eriksson P; Lundman P; Samnegård A; Boquist S; Ericsson CG; Tornvall P; Hamsten A; Silveira A
    Thromb Haemost; 2005 Mar; 93(3):570-7. PubMed ID: 15735812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen genes and myocardial infarction: a haplotype analysis.
    Koch W; Hoppmann P; Biele J; Mueller JC; Schömig A; Kastrati A
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):758-63. PubMed ID: 18202324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen gene variation and ischemic stroke.
    Jood K; Danielson J; Ladenvall C; Blomstrand C; Jern C
    J Thromb Haemost; 2008 Jun; 6(6):897-904. PubMed ID: 18331453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study.
    Fisher E; Stefan N; Saar K; Drogan D; Schulze MB; Fritsche A; Joost HG; Häring HU; Hubner N; Boeing H; Weikert C
    Circ Cardiovasc Genet; 2009 Dec; 2(6):607-13. PubMed ID: 20031641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
    Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
    Reiner AP; Carty CL; Carlson CS; Wan JY; Rieder MJ; Smith JD; Rice K; Fornage M; Jaquish CE; Williams OD; Tracy RP; Lewis CE; Siscovick DS; Boerwinkle E; Nickerson DA
    J Thromb Haemost; 2006 Jun; 4(6):1279-87. PubMed ID: 16706972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.
    Rioux JD; Daly MJ; Silverberg MS; Lindblad K; Steinhart H; Cohen Z; Delmonte T; Kocher K; Miller K; Guschwan S; Kulbokas EJ; O'Leary S; Winchester E; Dewar K; Green T; Stone V; Chow C; Cohen A; Langelier D; Lapointe G; Gaudet D; Faith J; Branco N; Bull SB; McLeod RS; Griffiths AM; Bitton A; Greenberg GR; Lander ES; Siminovitch KA; Hudson TJ
    Nat Genet; 2001 Oct; 29(2):223-8. PubMed ID: 11586304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies.
    Smith GD; Harbord R; Milton J; Ebrahim S; Sterne JA
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2228-33. PubMed ID: 16123313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-centric association signals for haemostasis and thrombosis traits identified with the HumanCVD BeadChip.
    Gaunt TR; Zabaneh D; Shah S; Guyatt A; Ladroue C; Kumari M; Drenos F; Shah T; Talmud PJ; Casas JP; Lowe G; Rumley A; Lawlor DA; Kivimaki M; Whittaker J; Hingorani AD; Humphries SE; Day IN
    Thromb Haemost; 2013 Nov; 110(5):995-1003. PubMed ID: 24178511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic effects for plasma factor VII levels independent of and in common with triglycerides.
    Hong Y; Pedersen NL; Egberg N; de Faire U
    Thromb Haemost; 1999 Mar; 81(3):382-6. PubMed ID: 10102465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease.
    Folkersen L; van't Hooft F; Chernogubova E; Agardh HE; Hansson GK; Hedin U; Liska J; Syvänen AC; Paulsson-Berne G; Franco-Cereceda A; Hamsten A; Gabrielsen A; Eriksson P;
    Circ Cardiovasc Genet; 2010 Aug; 3(4):365-73. PubMed ID: 20562444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma.
    Bernardi F; Marchetti G; Pinotti M; Arcieri P; Baroncini C; Papacchini M; Zepponi E; Ursicino N; Chiarotti F; Mariani G
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):72-6. PubMed ID: 8548429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
    Mannila MN; Eriksson P; Ericsson CG; Hamsten A; Silveira A
    Thromb Haemost; 2006 Mar; 95(3):420-7. PubMed ID: 16525568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study.
    Theodoraki EV; Nikopensius T; Suhorutsenko J; Peppes V; Fili P; Kolovou G; Papamikos V; Richter D; Zakopoulos N; Krjutskov K; Metspalu A; Dedoussis GV
    BMC Med Genet; 2010 Feb; 11():28. PubMed ID: 20167083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.